Leukemia

Journal Abbreviation: LEUKEMIA
ISSN: 0887-6924
eISSN: 1476-5551
Publisher: Springer Nature

Publications (76)

close-button

Types of publications

Journal article
Unpublished / Preprint

Publication year

From
To

Abstract

Azacitidine in combination with intensive induction chemotherapy in older patients with acute myeloid leukemia: The AML-AZA trial of the study alliance leukemia (2016) Mueller-Tidow C, Tschanter P, Roellig C, Thiede C, Koschmieder A, Stelljes M, Koschmieder S, et al. Journal article The PD-1/PD-L1 axis contributes to immune metabolic dysfunctions of monocytes in chronic lymphocytic leukemia (2016) Qorraj M, Bruns H, Böttcher M, Weigand L, Saul D, Mackensen A, Jitschin R, Mougiakakos D Journal article Clofarabine salvage therapy before allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory AML: results of the BRIDGE trial (2016) Middeke JM, Herbst R, Parmentier S, Bug G, Haenel M, Stuhlers G, Schaefer-Eckart K, et al. Journal article Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV (2016) Miranda MB, Lauseker M, Kraus MP, Proetel U, Hanfstein B, Fabarius A, Baerlocher GM, et al. Journal article High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study) (2016) Fritsch K, Kasenda B, Schorb E, Hau P, Bloehdorn J, Moehle R, Loew S, et al. Journal article Hematopoietic cell transplantation in patients with intermediate and high-risk AML: results from the randomized Study Alliance Leukemia (SAL) AML 2003 trial (2015) Schetelig J, Schaich M, Schaefer-Eckart K, Haenel M, Aulitzky WE, Einsele H, Schmitz N, et al. Journal article Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IV (2015) Kalmanti L, Saussele S, Lauseker M, Mueller MC, Dietz CT, Heinrich L, Hanfstein B, et al. Journal article Insulin-like growth factor 1 is a direct HOXA9 target important for hematopoietic transformation (2015) Steger J, Füller E, Garcia-Cuellar MP, Hetzner K, Slany R Journal article, Original article Velocity of early BCR-ABL transcript elimination as an optimized predictor of outcome in chronic myeloid leukemia (CML) patients in chronic phase on treatment with imatinib (2014) Hanfstein B, Shlyakhto V, Lauseker M, Hehlmann R, Saussele S, Dietz C, Erben P, et al. Journal article Efficient generation of human natural killer cell lines by viral transformation (2014) Vogel B, Tennert K, Full F, Enßer A Journal article